(EMAILWIRE.COM, April 25, 2015 ) Albany, NY — This report provides comprehensive information on the therapeutic development for Inclusion Body Myositis (IBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration…
http://www.emailwire.com/release/183815-Therapeutic-Development-for-Inclusion-Body-Myositis-IBM-and-Pipeline-Review-2015.html